Masaaki Takeyasu
Keine laufenden Positionen mehr
Profil
Masaaki Takeyasu served as the Chairman of C&O Pharmaceutical Technology (Holdings) Ltd.
from 2011 to 2012.
He also worked as the Executive Officer & GM-Overseas Business at Shionogi & Co., Ltd.
from 1988 to 2016.
Takeyasu received his undergraduate degree from the University of Tokyo in 1988.
Ehemalige bekannte Positionen von Masaaki Takeyasu
| Unternehmen | Position | Ende |
|---|---|---|
| SHIONOGI & CO., LTD. | Corporate Officer/Principal | - |
C&O Pharmaceutical Technology (Holdings) Ltd.
 C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Vorsitzender | - |
Ausbildung von Masaaki Takeyasu
| University of Tokyo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHIONOGI & CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
C&O Pharmaceutical Technology (Holdings) Ltd.
C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong. | Health Technology |
